Press Release: MapmyGenome Partners with CARE Hospitals to Offer Personal Genomics and Molecular Diagnostics
Hyderabad, India — August 1, 2014: MapmyGenome India has partnered with CARE Hospitals Group to offer personal genomics and molecular diagnostics at the hospital. Patients at CARE can avail of genetic risk prediction tests at the Outpatient Centre in Banjara Hills, Hyderabad.
“We are excited about partnering with a progressive group like CARE Hospitals. CARE Hospitals Group with its reputation for transparency, ethical practice and affordability will make personal genomics more reachable to people.” — Anu Acharya, CEO, MapmyGenome
“The partnership with MapmyGenome is in line with our commitment to make technological advances available to our patients, besides the opportunity to work together on areas of mutual interest in research.” — Dilip Jose, Group CEO, CARE Hospitals
“Mapping the genome will help in predicting, preventing and treating a number of diseases. The collaboration will open up new possibilities and help in understanding the gene-disease interaction better.” — Dr Rajeev Menon, Chief of Medical Services, CARE Hospitals
About CARE Hospitals
The CARE Hospitals Group is a multispecialty healthcare provider with 15 hospitals serving 9 cities across 6 states of India — a regional leader in tertiary care in South/Central India and among the top 5 pan-Indian hospital chains.
About MapmyGenome
MapmyGenome is India’s pioneering personal genomics and molecular diagnostics company. Their portfolio includes Genomepatri™, Cardiomap™, Oncomap™, Brainmap™, Gynaecmap™, and SMART SPORT™, along with genetic counselling, nutrition counselling, and TB diagnostic kits.
MapmyGenome — Personal Genomics Now Available Near You
Genomepatri by MapmyGenome is India’s most comprehensive at-home DNA wellness test — covering 100+ health conditions, nutrition, fitness, and drug response traits. Available online and through healthcare partners across India.
